 |
|
|
| |
Pharmacokinetics (PK) and PK-Pharmacodynamic (PD) Relationship of Dolutegravir (DTG) in Integrase Inhibitor (INI)-Naive Subjects
|
| |
| |
Reported by Jules Levin
53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 10-13, 2013; Denver, CO
Ivy Song,1 Shuguang Chen,2 Stephen Piscitelli,3 Sherene Min3
1Clinical Pharmacology Modeling & Simulation, 2Clinical Statistics, 3Infectious Diseases Therapeutic Area Unit, GlaxoSmithKline, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
